Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	axon guidance receptor activity	EPHB3 MYOT HMCN2	7.02e-05	13	128	3	GO:0008046
GeneOntologyMolecularFunction	cell adhesion mediator activity	MYOT NRCAM DSCAM DSCAML1 SVEP1	1.28e-04	76	128	5	GO:0098631
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 SNAI2 ZNF724 ZNF723 ZFP2 ZNF426 ZNF286A	2.46e-04	1412	128	21	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 SNAI2 ZNF724 ZNF723 ZFP2 ZNF426 ZNF286A	3.82e-04	1459	128	21	GO:0000977
GeneOntologyBiologicalProcess	dendrite self-avoidance	MYOT NRCAM DSCAM DSCAML1	4.31e-06	18	130	4	GO:0070593
GeneOntologyBiologicalProcess	neuron recognition	EPHB3 MYOT NRCAM DSCAM DSCAML1	3.51e-05	59	130	5	GO:0008038
GeneOntologyBiologicalProcess	sensory perception	COL2A1 MKKS COL11A1 ABCA4 OR7A5 MYO6 TMEM87A ITPR3 OR51A7 OR52K1 EYS HMCN1 OR4A15 SNAI2 RIMS1 OR7A17 OR52K2 KIT OR7A10	4.25e-05	1072	130	19	GO:0007600
GeneOntologyBiologicalProcess	telencephalon development	EPHB3 MKKS NCOR2 CELF1 SYNE2 AFDN DCLK2 MDGA1 FBXO45 EPHA5	4.93e-05	332	130	10	GO:0021537
GeneOntologyBiologicalProcess	cell junction assembly	EPHB3 OGT NRCAM DSCAM MYO6 LRRTM3 THSD1 TLN1 SNAI2 MACF1 AFDN MDGA1 FBXO45	6.42e-05	569	130	13	GO:0034329
GeneOntologyBiologicalProcess	head development	COL2A1 EPHB3 MKKS NRCAM WNT9B ITGA4 DSCAML1 NCOR2 CELF1 SYNE2 SEC24B AFDN DCLK2 MDGA1 FBXO45 TOP2B EPHA5	6.64e-05	919	130	17	GO:0060322
GeneOntologyBiologicalProcess	pallium development	MKKS CELF1 SYNE2 AFDN DCLK2 MDGA1 FBXO45 EPHA5	8.37e-05	222	130	8	GO:0021543
GeneOntologyBiologicalProcess	cell junction organization	EPHB3 OGT MYOT NRCAM DSCAM MYO6 LRRTM3 THSD1 SVEP1 HMCN2 TLN1 SNAI2 MACF1 AFDN MDGA1 FBXO45 EPHA5	1.34e-04	974	130	17	GO:0034330
GeneOntologyBiologicalProcess	synapse assembly	EPHB3 OGT NRCAM DSCAM MYO6 LRRTM3 AFDN MDGA1 FBXO45	1.49e-04	308	130	9	GO:0007416
GeneOntologyBiologicalProcess	positive regulation of excitatory postsynaptic potential	NETO2 NETO1 AFDN RIMS1	1.54e-04	43	130	4	GO:2000463
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	MYOT NRCAM DSCAM PCDHB12 ITGA4 DSCAML1 HMCN2 HMCN1 MDGA1	1.68e-04	313	130	9	GO:0098742
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	MYOT NRCAM DSCAM PCDHB12 DSCAML1 HMCN2 HMCN1	1.86e-04	187	130	7	GO:0007156
MousePheno	abnormal somatic sensory system morphology	MKKS COL11A1 USP45 ABCA4 DSCAM MYO6 ABCB5 DSCAML1 PPARGC1A SYNE2 SEC24B MACF1 FBXO45 KIT EPHA5	2.53e-05	702	87	15	MP:0000959
MousePheno	abnormal sensory neuron morphology	COL11A1 USP45 ABCA4 DSCAM MYO6 ABCB5 DSCAML1 PPARGC1A SYNE2 MACF1 FBXO45 EPHA5	3.47e-05	473	87	12	MP:0000965
MousePheno	abnormal somatic nervous system morphology	COL2A1 MKKS COL11A1 USP45 ABCA4 DSCAM MYO6 ABCB5 ZNF329 DSCAML1 PPARGC1A HMCN1 SYNE2 SEC24B MACF1 FBXO45 KIT EPHA5	4.90e-05	1025	87	18	MP:0002752
Domain	zf-C2H2_6	ZNF765 ZNF136 ZNF493 ZNF329 ZNF571 ZNF20 ZNF182 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	4.76e-10	314	128	16	PF13912
Domain	IGc2	FLT1 MXRA5 MYOT NRCAM DSCAM DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 KIT MYBPC1	7.80e-08	235	128	12	SM00408
Domain	Ig_sub2	FLT1 MXRA5 MYOT NRCAM DSCAM DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 KIT MYBPC1	7.80e-08	235	128	12	IPR003598
Domain	Ig_I-set	FLT1 MXRA5 MYOT NRCAM DSCAM DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 MYBPC1	7.82e-08	190	128	11	IPR013098
Domain	I-set	FLT1 MXRA5 MYOT NRCAM DSCAM DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 MYBPC1	7.82e-08	190	128	11	PF07679
Domain	KRAB	ZNF765 ZNF136 ZNF180 ZNF571 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 ZNF426 ZNF286A	1.70e-07	358	128	14	PS50805
Domain	-	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	1.87e-07	679	128	19	3.30.160.60
Domain	KRAB	ZNF765 ZNF136 ZNF180 ZNF571 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 ZNF426 ZNF286A	2.45e-07	369	128	14	SM00349
Domain	KRAB	ZNF765 ZNF136 ZNF180 ZNF571 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 ZNF426 ZNF286A	2.53e-07	370	128	14	IPR001909
Domain	zf-C2H2	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	2.56e-07	693	128	19	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	2.62e-07	694	128	19	IPR013087
Domain	ZINC_FINGER_C2H2_2	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 BRPF1 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	3.14e-07	775	128	20	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 BRPF1 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	3.27e-07	777	128	20	PS00028
Domain	Znf_C2H2-like	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 BRPF1 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	4.79e-07	796	128	20	IPR015880
Domain	Znf_C2H2	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 BRPF1 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	5.71e-07	805	128	20	IPR007087
Domain	ZnF_C2H2	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 BRPF1 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	6.05e-07	808	128	20	SM00355
Domain	KRAB	ZNF765 ZNF136 ZNF180 ZNF571 ZNF20 ZNF182 ZNF776 ZNF732 ZNF253 ZNF92 ZNF283 ZNF426 ZNF286A	1.10e-06	358	128	13	PF01352
Domain	Ig-like_fold	EPHB3 FLT1 MXRA5 MYOT NRCAM DSCAM HLA-DOB DSCAML1 MFAP3L FSD1L HMCN2 HMCN1 MDGA1 KIT MYBPC1 EPHA5	2.66e-05	706	128	16	IPR013783
Domain	IG_LIKE	FLT1 MXRA5 MYOT NRCAM DSCAM HLA-DOB DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 KIT MYBPC1	3.31e-05	491	128	13	PS50835
Domain	IG	FLT1 MXRA5 MYOT NRCAM DSCAM DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 KIT MYBPC1	3.31e-05	421	128	12	SM00409
Domain	Ig_sub	FLT1 MXRA5 MYOT NRCAM DSCAM DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 KIT MYBPC1	3.31e-05	421	128	12	IPR003599
Domain	FN3	EPHB3 NRCAM DSCAM DSCAML1 FSD1L MDGA1 MYBPC1 EPHA5	4.14e-05	185	128	8	SM00060
Domain	Ig-like_dom	FLT1 MXRA5 MYOT NRCAM DSCAM HLA-DOB DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 KIT MYBPC1	4.24e-05	503	128	13	IPR007110
Domain	-	EPHB3 FLT1 MXRA5 MYOT NRCAM DSCAM HLA-DOB DSCAML1 MFAP3L FSD1L HMCN1 MDGA1 KIT MYBPC1 EPHA5	4.93e-05	663	128	15	2.60.40.10
Domain	FN3	EPHB3 NRCAM DSCAM DSCAML1 FSD1L MDGA1 MYBPC1 EPHA5	6.92e-05	199	128	8	PS50853
Domain	FN3_dom	EPHB3 NRCAM DSCAM DSCAML1 FSD1L MDGA1 MYBPC1 EPHA5	9.75e-05	209	128	8	IPR003961
Domain	fn3	EPHB3 NRCAM DSCAM DSCAML1 FSD1L MYBPC1 EPHA5	1.27e-04	162	128	7	PF00041
Domain	G2F	HMCN2 HMCN1	2.77e-04	4	128	2	PF07474
Domain	NIDOGEN_G2	HMCN2 HMCN1	2.77e-04	4	128	2	PS50993
Domain	GFP	HMCN2 HMCN1	2.77e-04	4	128	2	IPR009017
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	2.77e-04	4	128	2	IPR006605
Domain	ig	FLT1 NRCAM DSCAM DSCAML1 HMCN1 MDGA1 KIT	3.39e-04	190	128	7	PF00047
Domain	Immunoglobulin	FLT1 NRCAM DSCAM DSCAML1 HMCN1 MDGA1 KIT	3.39e-04	190	128	7	IPR013151
Domain	EGF_2	HYAL4 ADAM21 ADAM28 SVEP1 EYS HMCN2 HMCN1 EPHA5	4.88e-04	265	128	8	PS01186
Domain	Ephrin_rec_like	EPHB3 SVEP1 EPHA5	6.48e-04	25	128	3	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB3 SVEP1 EPHA5	6.48e-04	25	128	3	IPR011641
Domain	FAT	TRRAP TMTC1	6.87e-04	6	128	2	PF02259
Domain	PIK-rel_kinase_FAT	TRRAP TMTC1	6.87e-04	6	128	2	IPR003151
Domain	Growth_fac_rcpt_	EPHB3 SVEP1 EYS HMCN2 HMCN1 EPHA5	7.24e-04	156	128	6	IPR009030
Domain	Tyr_kinase_rcpt_3_CS	FLT1 KIT	1.27e-03	8	128	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	FLT1 KIT	1.27e-03	8	128	2	PS00240
Domain	IGv	FLT1 DSCAM DSCAML1 HMCN1	1.76e-03	75	128	4	SM00406
Domain	EGF_1	HYAL4 ADAM21 ADAM28 SVEP1 EYS HMCN2 HMCN1	1.90e-03	255	128	7	PS00022
Domain	HAT	TMTC1 PDCD11	2.02e-03	10	128	2	SM00386
Domain	HAT	TMTC1 PDCD11	2.02e-03	10	128	2	IPR003107
Domain	EGF-like_CS	ADAM21 ADAM28 SVEP1 EYS HMCN2 HMCN1 EPHA5	2.16e-03	261	128	7	IPR013032
Domain	Pept_his_AS	CTSF CTSC	2.46e-03	11	128	2	IPR025660
Domain	GFP-like	SVEP1 HMCN1	2.46e-03	11	128	2	IPR023413
Domain	Ephrin_rec_like	EPHB3 SVEP1	2.46e-03	11	128	2	PF07699
Domain	NC1_FIB	COL2A1 COL11A1	2.46e-03	11	128	2	PS51461
Domain	Fib_collagen_C	COL2A1 COL11A1	2.46e-03	11	128	2	PD002078
Domain	-	SVEP1 HMCN1	2.46e-03	11	128	2	2.40.155.10
Domain	Fib_collagen_C	COL2A1 COL11A1	2.46e-03	11	128	2	IPR000885
Domain	COLFI	COL2A1 COL11A1	2.46e-03	11	128	2	PF01410
Domain	COLFI	COL2A1 COL11A1	2.46e-03	11	128	2	SM00038
Domain	ABC_transporter_CS	ABCA4 ABCB5 ABCC9	2.97e-03	42	128	3	IPR017871
Domain	Tyr_kinase_cat_dom	EPHB3 FLT1 KIT EPHA5	3.15e-03	88	128	4	IPR020635
Domain	TyrKc	EPHB3 FLT1 KIT EPHA5	3.15e-03	88	128	4	SM00219
Domain	Pept_C1	CTSF CTSC	3.46e-03	13	128	2	SM00645
Domain	Peptidase_C1A_C	CTSF CTSC	3.46e-03	13	128	2	IPR000668
Domain	Peptidase_C1	CTSF CTSC	3.46e-03	13	128	2	PF00112
Domain	Peptidase_C1A	CTSF CTSC	3.46e-03	13	128	2	IPR013128
Domain	RECEPTOR_TYR_KIN_V_2	EPHB3 EPHA5	4.02e-03	14	128	2	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHB3 EPHA5	4.02e-03	14	128	2	PS00790
Domain	Tyr_kinase_rcpt_V_CS	EPHB3 EPHA5	4.02e-03	14	128	2	IPR001426
Domain	EphA2_TM	EPHB3 EPHA5	4.02e-03	14	128	2	PF14575
Domain	Ephrin_rcpt_lig-bd_dom	EPHB3 EPHA5	4.02e-03	14	128	2	IPR001090
Domain	Eph_TM	EPHB3 EPHA5	4.02e-03	14	128	2	IPR027936
Domain	EPH_lbd	EPHB3 EPHA5	4.02e-03	14	128	2	SM00615
Domain	Ephrin_lbd	EPHB3 EPHA5	4.02e-03	14	128	2	PF01404
Domain	Tyr_kinase_ephrin_rcpt	EPHB3 EPHA5	4.02e-03	14	128	2	IPR016257
Domain	EPH_LBD	EPHB3 EPHA5	4.02e-03	14	128	2	PS51550
Domain	ConA-like_dom	COL11A1 SVEP1 FSD1L EYS MDGA1 FBXO45	4.02e-03	219	128	6	IPR013320
Domain	ABC_tran	ABCA4 ABCB5 ABCC9	4.34e-03	48	128	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCA4 ABCB5 ABCC9	4.34e-03	48	128	3	PS50893
Domain	PROTEIN_KINASE_TYR	EPHB3 FLT1 KIT EPHA5	4.46e-03	97	128	4	PS00109
Domain	EGF_Ca-bd_CS	SVEP1 EYS HMCN2 HMCN1	4.46e-03	97	128	4	IPR018097
Domain	Tyr_kinase_AS	EPHB3 FLT1 KIT EPHA5	4.46e-03	97	128	4	IPR008266
Domain	ABC_TRANSPORTER_1	ABCA4 ABCB5 ABCC9	4.60e-03	49	128	3	PS00211
Domain	EGF_CA	SVEP1 EYS HMCN2 HMCN1	4.80e-03	99	128	4	PS01187
Domain	VWF_A	SVEP1 HMCN2 HMCN1 SEC24B	4.80e-03	99	128	4	IPR002035
Domain	ABC_transporter-like	ABCA4 ABCB5 ABCC9	4.87e-03	50	128	3	IPR003439
Domain	ASX_HYDROXYL	SVEP1 EYS HMCN2 HMCN1	4.97e-03	100	128	4	PS00010
Domain	-	TRRAP PIK3CD	5.25e-03	16	128	2	1.10.1070.11
Domain	PI3Kc	TRRAP PIK3CD	5.25e-03	16	128	2	SM00146
Domain	Disintegrin_CS	ADAM21 ADAM28	5.25e-03	16	128	2	IPR018358
Domain	EGF_3	ADAM21 ADAM28 SVEP1 EYS HMCN2 HMCN1	5.65e-03	235	128	6	PS50026
Domain	EGF-type_Asp/Asn_hydroxyl_site	SVEP1 EYS HMCN2 HMCN1	6.10e-03	106	128	4	IPR000152
Domain	PI3_PI4_kinase	TRRAP PIK3CD	6.64e-03	18	128	2	PF00454
Domain	PI3_4_KINASE_1	TRRAP PIK3CD	6.64e-03	18	128	2	PS00915
Domain	PI3_4_KINASE_2	TRRAP PIK3CD	6.64e-03	18	128	2	PS00916
Domain	ADAM_CR	ADAM21 ADAM28	6.64e-03	18	128	2	PF08516
Domain	PI3/4_kinase_cat_dom	TRRAP PIK3CD	6.64e-03	18	128	2	IPR000403
Domain	PI3_4_KINASE_3	TRRAP PIK3CD	6.64e-03	18	128	2	PS50290
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	CUL1 ZNF136 ZNF493 ZNF180 ZNF571 WDR5 ITGA4 THOC5 PPARGC1A NCOR2 ZNF20 ZNF776 ZNF676 INTS2 ZNF732 ZNF253 ZNF92 BRPF1 ZNF724 CSTF1 KIT ZFP2 ZNF426 ZNF286A	3.36e-05	1387	101	24	M734
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF136 ZNF493 ZCCHC4 ZNF20 ZNF182 ZNF776 ZNF253 ZNF92 ZNF724	3.14e-08	181	131	9	37372979
Pubmed	Visualizing an olfactory sensory map.	OR7A5 OR7A17 OR7A10	1.04e-06	6	131	3	8929536
Pubmed	Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells.	DDX17 TRRAP NCOR2	6.15e-06	10	131	3	12738788
Pubmed	Differential impact of Lhx2 deficiency on expression of class I and class II odorant receptor genes in mouse.	OR52K1 OR7A17 OR52K2 OR7A10	7.23e-06	33	131	4	17350283
Pubmed	HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.	TRRAP TMEM87A MACF1 ZFP2	8.17e-06	34	131	4	25925205
Pubmed	Transcriptional analysis of cleft palate in TGFβ3 mutant mice.	COL2A1 COL11A1 NRCAM WNT9B	9.19e-06	35	131	4	32913205
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	WAPL DDX17 OGT WDR5 TRRAP INTS2 PDCD11 TOP2B	9.53e-06	272	131	8	31010829
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	WAPL OGT WDR5 NCOR2 FEN1 AFDN TOP2B	1.26e-05	203	131	7	22083510
Pubmed	VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.	FLT1 ABCB5	1.41e-05	2	131	2	21212411
Pubmed	Incidence of mandibular distraction osteogenesis in Stickler Syndrome: Variation due to COL2A1 and COL11A1.	COL2A1 COL11A1	1.41e-05	2	131	2	34004386
Pubmed	Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis.	COL2A1 ABCA4	1.41e-05	2	131	2	18523590
Pubmed	Mutation Spectrum and De Novo Mutation Analysis in Stickler Syndrome Patients with High Myopia or Retinal Detachment.	COL2A1 COL11A1	1.41e-05	2	131	2	32756486
Pubmed	Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1.	COL2A1 COL11A1	1.41e-05	2	131	2	20513134
Pubmed	Human down syndrome cell adhesion molecules (DSCAMs) are functionally conserved with Drosophila Dscam[TM1] isoforms in controlling neurodevelopment.	DSCAM DSCAML1	1.41e-05	2	131	2	21645617
Pubmed	NETO1 Regulates Postsynaptic Kainate Receptors in CA3 Interneurons During Circuit Maturation.	NETO2 NETO1	1.41e-05	2	131	2	31044365
Pubmed	Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction.	NETO2 NETO1	1.41e-05	2	131	2	30770891
Pubmed	Genetic Characteristics and Phenotype of Korean Patients with Stickler Syndrome: A Korean Multicenter Analysis Report No. 1.	COL2A1 COL11A1	1.41e-05	2	131	2	34680973
Pubmed	A novel gene encoding a putative transmembrane protein with two extracellular CUB domains and a low-density lipoprotein class A module: isolation of alternatively spliced isoforms in retina and brain.	NETO2 NETO1	1.41e-05	2	131	2	11943477
Pubmed	Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice.	PLA2G2A MUC2	1.41e-05	2	131	2	19037975
Pubmed	Expression of Btcl2, a novel member of Btcl gene family, during development of the central nervous system.	NETO2 NETO1	1.41e-05	2	131	2	15464227
Pubmed	NETO1 Guides Development of Glutamatergic Connectivity in the Hippocampus by Regulating Axonal Kainate Receptors.	NETO2 NETO1	1.41e-05	2	131	2	28680963
Pubmed	Expanding the phenotype spectrum associated with pathogenic variants in the COL2A1 and COL11A1 genes.	COL2A1 COL11A1	1.41e-05	2	131	2	32427345
Pubmed	Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes.	COL2A1 COL11A1	1.41e-05	2	131	2	10486316
Pubmed	Mutation survey and genotype-phenotype analysis of COL2A1 and COL11A1 genes in 16 Chinese patients with Stickler syndrome.	COL2A1 COL11A1	1.41e-05	2	131	2	27390512
Pubmed	Host genetic and epigenetic factors in toxoplasmosis.	COL2A1 ABCA4	1.41e-05	2	131	2	19430638
Pubmed	Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis.	CTSC KIT	1.41e-05	2	131	2	19850030
Pubmed	Changes in type II procollagen isoform expression during chondrogenesis by disruption of an alternative 5' splice site within Col2a1 exon 2.	COL2A1 COL11A1	1.41e-05	2	131	2	24735995
Pubmed	Hearing Outcomes in Stickler Syndrome: Variation Due to COL2A1 and COL11A1.	COL2A1 COL11A1	1.41e-05	2	131	2	34238052
Pubmed	The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1.	ITGA4 ADAM28	1.41e-05	2	131	2	11724793
Pubmed	Splicing analysis of unclassified variants in COL2A1 and COL11A1 identifies deep intronic pathogenic mutations.	COL2A1 COL11A1	1.41e-05	2	131	2	22189268
Pubmed	C-kit induces epithelial-mesenchymal transition and contributes to salivary adenoid cystic cancer progression.	SNAI2 KIT	1.41e-05	2	131	2	24721839
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	1.41e-05	2	131	2	32035013
Pubmed	KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis.	KDM3A PPARGC1A	1.41e-05	2	131	2	31629659
Pubmed	The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.	PIK3CD KIT	1.41e-05	2	131	2	24213578
Pubmed	DSCAM and DSCAML1 regulate the radial migration and callosal projection in developing cerebral cortex.	DSCAM DSCAML1	1.41e-05	2	131	2	25451118
Pubmed	THSD1 (Thrombospondin Type 1 Domain Containing Protein 1) Mutation in the Pathogenesis of Intracranial Aneurysm and Subarachnoid Hemorrhage.	THSD1 TLN1	1.41e-05	2	131	2	27895300
Pubmed	Phenotypic characterization of patients with early-onset high myopia due to mutations in COL2A1 or COL11A1: Why not Stickler syndrome?	COL2A1 COL11A1	1.41e-05	2	131	2	30181686
Pubmed	Mammalian DSCAMs: roles in the development of the spinal cord, cortex, and cerebellum?	DSCAM DSCAML1	1.41e-05	2	131	2	12051741
Pubmed	Neto auxiliary protein interactions regulate kainate and NMDA receptor subunit localization at mossy fiber-CA3 pyramidal cell synapses.	NETO2 NETO1	1.41e-05	2	131	2	24403160
Pubmed	SLUG (SNAI2) deletions in patients with Waardenburg disease.	SNAI2 KIT	1.41e-05	2	131	2	12444107
Pubmed	Multispecies RNA tomography reveals regulators of hematopoietic stem cell birth in the embryonic aorta.	SVEP1 PPARGC1A KIT	1.45e-05	13	131	3	32457985
Pubmed	Evolution of odorant receptors expressed in mammalian testes.	OR7A5 OR7A17 OR7A10	1.45e-05	13	131	3	11014824
Pubmed	DSCAM promotes axon fasciculation and growth in the developing optic pathway.	NRCAM DSCAM DSCAML1	1.84e-05	14	131	3	28137836
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	DDX17 OGT WDR5 TRRAP NCOR2 FEN1 TOP2B	2.12e-05	220	131	7	35785414
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A WAPL OGT NRCAM DSCAM MYO6 KDM4C ZNF329 ZNFX1 SEC31A DSCAML1 NETO1 ZNF92 MACF1 AFDN DCLK2	2.81e-05	1285	131	16	35914814
Pubmed	A protein interaction landscape of breast cancer.	MYO6 SEC31A THOC5 FAM83B ITPR3 TLN1 CSTF1 PDCD11 MACF1 LSS TOP2B	2.98e-05	634	131	11	34591612
Pubmed	Chromosomal location-dependent nonstochastic onset of odor receptor expression.	OR7A5 OR7A17 OR7A10	3.42e-05	17	131	3	20668191
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	FLT1 NRCAM DSCAM DSCAML1 HMCN1 MDGA1	3.60e-05	162	131	6	25826454
Pubmed	Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.	HMCN2 HMCN1	4.21e-05	3	131	2	12388743
Pubmed	Mast cell dipeptidyl peptidase I mediates survival from sepsis.	CTSC KIT	4.21e-05	3	131	2	14966572
Pubmed	Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells.	SNAI2 KIT	4.21e-05	3	131	2	15337769
Pubmed	Investigation of genotype-phenotype relationship in Turkish patients with inherited retinal disease by next generation sequencing.	ABCA4 EYS	4.21e-05	3	131	2	34315337
Pubmed	The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug.	SNAI2 KIT	4.21e-05	3	131	2	12833143
Pubmed	Col11a1 and Col11a2 mRNA expression in the developing mouse cochlea: implications for the correlation of hearing loss phenotype with mutant type XI collagen genotype.	COL2A1 COL11A1	4.21e-05	3	131	2	15141750
Pubmed	Replacing the PDZ-interacting C-termini of DSCAM and DSCAML1 with epitope tags causes different phenotypic severity in different cell populations.	DSCAM DSCAML1	4.21e-05	3	131	2	27637097
Pubmed	Neto2 Assembles with Kainate Receptors in DRG Neurons during Development and Modulates Neurite Outgrowth in Adult Sensory Neurons.	NETO2 NETO1	4.21e-05	3	131	2	28235897
Pubmed	Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution.	CTSC KIT	4.21e-05	3	131	2	19297327
Pubmed	Expression analysis of the Adam21 gene in mouse testis.	ADAM21 KIT	4.21e-05	3	131	2	20117247
Pubmed	A secreted protein promotes cleavage furrow maturation during cytokinesis.	HMCN2 HMCN1	4.21e-05	3	131	2	21215633
Pubmed	Histochemical, immunofluorescence, and ultrastructural differences in fetal cartilage among three genetically distinct chondrodystrophic mice.	COL2A1 COL11A1	4.21e-05	3	131	2	3070812
Pubmed	MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses.	MACF1 TOP2B	4.21e-05	3	131	2	30842214
Pubmed	HAT cofactor TRRAP mediates beta-catenin ubiquitination on the chromatin and the regulation of the canonical Wnt pathway.	CUL1 TRRAP	4.21e-05	3	131	2	19066453
Pubmed	Genetic alterations and changes in expression of histone demethylases in prostate cancer.	KDM3A KDM4C	4.21e-05	3	131	2	20127736
Pubmed	Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9.	COL2A1 PPARGC1A	4.21e-05	3	131	2	15699338
Pubmed	Hemicentins assemble on diverse epithelia in the mouse.	HMCN2 HMCN1	4.21e-05	3	131	2	17015624
Pubmed	Neto auxiliary proteins control both the trafficking and biophysical properties of the kainate receptor GluK1.	NETO2 NETO1	4.21e-05	3	131	2	26720915
Pubmed	Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure.	FLT1 ITGA4	4.21e-05	3	131	2	17964871
Pubmed	Secreted Phospholipase A2 Type IIA (sPLA2-IIA) Activates Integrins in an Allosteric Manner.	ITGA4 PLA2G2A	4.21e-05	3	131	2	27864802
Pubmed	A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells.	HYAL4 MYOT ADAM28 SBF2 MYBPC1	5.01e-05	105	131	5	23284306
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CUL1 WAPL DDX17 MYO6 WDR5 SEC31A TRRAP NCOR2 TLN1 SEC24B FEN1 CSTF1 PDCD11 MACF1 AFDN TOP2B	5.20e-05	1353	131	16	29467282
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	EPHB3 NRCAM MYO6 DSCAML1 SYNE2 MACF1 FBXO45 TOP2B	6.72e-05	358	131	8	32460013
Pubmed	Zfp296 negatively regulates H3K9 methylation in embryonic development as a component of heterochromatin.	KDM3A KDM4C KIT	7.63e-05	22	131	3	28963472
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	DDX17 ZNFX1 WDR5 SEC31A ITPR3 TLN1 FEN1 PTRH2 PDCD11 MACF1 AFDN	8.33e-05	711	131	11	33022573
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	EPHB3 NETO2 NETO1 MDGA1 EPHA5	8.39e-05	117	131	5	17145500
Pubmed	Expressed sequence tag analysis of human RPE/choroid for the NEIBank Project: over 6000 non-redundant transcripts, novel genes and splice variants.	FLT1 ABCC9 SEC31A DNAH14 NCOR2	8.39e-05	117	131	5	12107410
Pubmed	The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.	NETO2 NETO1	8.41e-05	4	131	2	26277340
Pubmed	Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse.	COL2A1 COL11A1	8.41e-05	4	131	2	17683922
Pubmed	Mesothelium of the murine allantois exhibits distinct regional properties.	ITGA4 AFDN	8.41e-05	4	131	2	21284019
Pubmed	Talin 1 and paxillin facilitate distinct steps in rapid VLA-4-mediated adhesion strengthening to vascular cell adhesion molecule 1.	ITGA4 TLN1	8.41e-05	4	131	2	17597073
Pubmed	RYK, a catalytically inactive receptor tyrosine kinase, associates with EphB2 and EphB3 but does not interact with AF-6.	EPHB3 AFDN	8.41e-05	4	131	2	11956217
Pubmed	Genetic evidence for convergence of c-Kit- and alpha4 integrin-mediated signals on class IA PI-3kinase and the Rac pathway in regulating integrin-directed migration in mast cells.	ITGA4 KIT	8.41e-05	4	131	2	12560232
Pubmed	Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway.	SNAI2 KIT	8.41e-05	4	131	2	12149208
Pubmed	Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.	FLT1 SNAI2	8.41e-05	4	131	2	25256553
Pubmed	Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2.	HMCN2 HMCN1	8.41e-05	4	131	2	36007682
Pubmed	The stem cell factor/Kit signalling pathway regulates mitochondrial function and energy expenditure.	PPARGC1A KIT	8.41e-05	4	131	2	24999927
Pubmed	The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1.	ITGA4 SVEP1	8.41e-05	4	131	2	35802072
Pubmed	Mutations in collagen genes resulting in metaphyseal and epiphyseal dysplasias.	COL2A1 COL11A1	8.41e-05	4	131	2	8579897
Pubmed	Efficient coupling of Sec23-Sec24 to Sec13-Sec31 drives COPII-dependent collagen secretion and is essential for normal craniofacial development.	SEC31A SEC24B	8.41e-05	4	131	2	18713835
Pubmed	Murine models of human genetic skeletal disorders.	COL2A1 COL11A1	8.41e-05	4	131	2	9205941
Pubmed	Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha.	KDM3A KDM4C	8.41e-05	4	131	2	18713068
Pubmed	Hemicentin-1 is an essential extracellular matrix component of the dermal-epidermal and myotendinous junctions.	HMCN2 HMCN1	8.41e-05	4	131	2	34504132
Pubmed	The olfactory receptor gene repertoire in primates and mouse: evidence for reduction of the functional fraction in primates.	OR7A5 OR7A17 OR7A10	8.75e-05	23	131	3	10706615
Pubmed	Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.	COL2A1 MXRA5 CTSC HMCN1	9.05e-05	62	131	4	28344315
Pubmed	Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species.	OR7A5 OR7A17 OR7A10	9.98e-05	24	131	3	9119360
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	WDR5 TLN1 SYNE2 SEC24B MACF1 ARHGAP20	1.06e-04	197	131	6	20811636
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3A ZNF136 WAPL OGT WDR5 TRRAP ZNF776 BRPF1 FEN1 TOP2B	1.08e-04	608	131	10	36089195
Pubmed	DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors.	NRCAM DSCAM MDGA1	1.27e-04	26	131	3	34848499
Pubmed	Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.	ITGA4 PLA2G2A	1.40e-04	5	131	2	25398877
Pubmed	D5Ucl1 and Els1 are closely linked to W on mouse chromosome 5 but lie distal to the W19H deletion.	KIT EPHA5	1.40e-04	5	131	2	8703124
Pubmed	Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk.	EPHB3 AFDN	1.40e-04	5	131	2	10932185
Cytoband	19p12	ZNF493 ZNF676 ZNF724 ZNF723	1.34e-04	90	131	4	19p12
Cytoband	6q16.2	USP45 TSTD3	2.87e-04	9	131	2	6q16.2
Cytoband	Ensembl 112 genes in cytogenetic band chr19p12	ZNF493 ZNF676 ZNF724 ZNF723	4.29e-04	122	131	4	chr19p12
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FLT1 MXRA5 MYOT NRCAM DSCAM DSCAML1 MFAP3L HMCN2 HMCN1 MDGA1 MYBPC1	2.66e-09	161	106	11	593
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF765 ZNF136 ZNF493 ZNF180 ZNF329 ZNF571 ZBTB37 ZNF20 ZNF182 ZNF776 ZNF676 ZNF732 ZNF253 ZNF92 ZNF283 SNAI2 ZFP2 ZNF426 ZNF286A	3.29e-08	718	106	19	28
GeneFamily	Immunoglobulin like domain containing	FLT1 MXRA5 NRCAM DSCAM DSCAML1 HMCN2 MDGA1 KIT	1.80e-05	193	106	8	594
GeneFamily	Fibronectin type III domain containing	EPHB3 NRCAM DSCAM DSCAML1 FSD1L MYBPC1 EPHA5	4.36e-05	160	106	7	555
GeneFamily	Fibulins	HMCN2 HMCN1	9.32e-04	8	106	2	556
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHB3 EPHA5	2.96e-03	14	106	2	1095
GeneFamily	Cathepsins	CTSF CTSC	3.40e-03	15	106	2	470
Coexpression	GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN	DSCAM SEC31A NCOR2 CSAD CSTF1 PDCD11 AFDN MAPKBP1	7.75e-06	200	131	8	M5274
ToppCell	critical-Lymphoid-NK\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTSF NRCAM OR7A5 ABCB5 MFAP3L SNAI2 KIT EPHA5	6.39e-08	180	131	8	5abf778395392244daaec876f306ed7e4f388686
ToppCell	NS-critical-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CTSF NRCAM OR7A5 ABCB5 MFAP3L SNAI2 KIT EPHA5	6.96e-08	182	131	8	dd1c59babf7211362452e3e264009d70004d99f6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 COL11A1 ABCA4 NRCAM DSCAML1 PPARGC1A HMCN1 EPHA5	7.57e-08	184	131	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 COL11A1 ABCA4 NRCAM DSCAML1 PPARGC1A HMCN1 EPHA5	7.57e-08	184	131	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 COL11A1 ABCA4 NRCAM DSCAML1 PPARGC1A HMCN1 EPHA5	7.57e-08	184	131	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 MYO6 THSD1 DYSF TMTC1 CLIC2 AFDN KIT	1.14e-07	194	131	8	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 MYO6 THSD1 DYSF TMTC1 CLIC2 AFDN KIT	1.14e-07	194	131	8	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	EPHB3 WDR5 DNAH14 MFAP3L NCOR2 HMCN2 KIT	4.86e-07	160	131	7	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRCAM ITGA4 WDFY4 ADAM28 HMSD CLIC2 MYBPC1	5.07e-07	161	131	7	cd41abb7ae659d3d314281783a0aaad562b26037
ToppCell	Leuk-UTI-Myeloid-cDC1\|Leuk-UTI / Disease, Lineage and Cell Type	HLA-DOB MFSD2B WDFY4 ADAM28 CLIC2 ARHGAP20 MYBPC1	8.22e-07	173	131	7	226bb8d881f32d65c60f5e4c034c6d465f8e7ba5
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL11A1 MXRA5 MYO6 SYT6 TMTC1 NETO1 SNAI2	1.43e-06	188	131	7	ed92cddf47defea2f904d36c7ae05ffa323349a9
ToppCell	COPD-Myeloid-DC_Mature\|Myeloid / Disease state, Lineage and Cell class	HLA-DOB ITGA4 DSCAML1 ADAM28 HMSD CLIC2 KIT	1.65e-06	192	131	7	baebd462f464e7d0e462d07a74bb5d685a9fc3b6
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 MYO6 THSD1 DYSF CLIC2 AFDN KIT	1.71e-06	193	131	7	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 THSD1 DYSF HMCN1 AFDN DCLK2 KIT	1.71e-06	193	131	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 MYO6 THSD1 DYSF CLIC2 AFDN KIT	1.71e-06	193	131	7	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	critical-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NRCAM OR7A5 ABCB5 MFAP3L SNAI2 KIT EPHA5	1.71e-06	193	131	7	6be11fef87af04ee7a3cc223882ccd4077caded9
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 THSD1 DYSF TMTC1 DCLK2 RIMS1 KIT	1.77e-06	194	131	7	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLT1 THSD1 DYSF TMTC1 DCLK2 RIMS1 KIT	1.77e-06	194	131	7	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	DDX17 HLA-DOB WDFY4 CLIC2 PIK3CD AKAP11 KIT	1.89e-06	196	131	7	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SYT6 SVEP1 SBF2 SNAI2 MACF1 AFDN ARHGAP20	1.96e-06	197	131	7	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	EPHB3 KDM4C MFSD2B BEND7 DCLK2 RIMS1 RASD2	2.16e-06	200	131	7	61bae10c8b12196d9cee766897971b81cb897191
ToppCell	(5)_Fibroblast-E\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CTSF MXRA5 ABCC9 SVEP1 SNAI2 PLA2G2A FKBP7	2.16e-06	200	131	7	75e5ecb05e965e24d569aa2ef5cdf740b1528c06
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EPHB3 WDR5 DNAH14 MFAP3L NCOR2 HMCN2	5.94e-06	152	131	6	ca23261d8ef263cc697b8d7e7cb2afec8bc564f2
ToppCell	Int-URO-Myeloid-cDC1\|Int-URO / Disease, Lineage and Cell Type	USP45 HLA-DOB WDFY4 ADAM28 CLIC2 ARHGAP20	9.18e-06	164	131	6	f4628a7ff0dc765a5337ab499b3d61fc25573a16
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DOB WDFY4 ADAM28 CLIC2 DCLK2 KIT	9.84e-06	166	131	6	b1bebcbe17386cb102b11d551e62d46156ce0c68
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_11\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DOB WDFY4 ADAM28 CLIC2 DCLK2 KIT	1.02e-05	167	131	6	e44743b20a7435c579d8e999ddc4ca119d6753f2
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MXRA5 CTSC ADAM28 SVEP1 SNAI2 ARHGAP20	1.09e-05	169	131	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	PBMC-Mild-cDC_11\|Mild / Compartment, Disease Groups and Clusters	HLA-DOB DYSF WDFY4 MFAP3L NETO2 KIT	1.42e-05	177	131	6	974305e4c0eff90134c4e58cf11b955d1eee0501
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DOB DSCAML1 ADAM28 NETO1 ZNF92 ARHGAP20	1.46e-05	178	131	6	5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 ITGA4 THSD1 DYSF CLIC2 AFDN	1.56e-05	180	131	6	30cf3c7ee29694eaccb89bf8053a82037d5c9f1d
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	COL11A1 MXRA5 SVEP1 HMCN1 NETO1 PLA2G2A	1.61e-05	181	131	6	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL2A1 CTSF COL11A1 MXRA5 PCDHB12 PLA2G2A	1.66e-05	182	131	6	bb7de0c93d8f59f13c990e425139b9348ca8027e
ToppCell	cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL2A1 CTSF COL11A1 MXRA5 PCDHB12 PLA2G2A	1.66e-05	182	131	6	507f095af4dff60f2c2b64d750477154084c3595
ToppCell	cellseq-Mesenchymal-Chondrocytic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL2A1 CTSF COL11A1 MXRA5 PCDHB12 PLA2G2A	1.66e-05	182	131	6	88bd17c07bd8443a0ede4e9dc7bc9d1230b42211
ToppCell	facs-Aorta-Heart-3m-Myeloid-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLA-DOB ITGA4 WDFY4 PIK3CD FEN1 KIT	1.71e-05	183	131	6	062ec08d66c923f90fee771b1bf8d98bdc7e6c1b
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ABCC9 LRRTM3 ITGA4 SVEP1 HMCN1 KIT	1.76e-05	184	131	6	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	343B-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	KDM3A ZNF329 ITPR3 FSD1L ZNF283 ARHGAP20	1.82e-05	185	131	6	1b8e3ddb91797f84e4b15d2457b0c008e5be50db
ToppCell	343B-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	KDM3A ZNF329 ITPR3 FSD1L ZNF283 ARHGAP20	1.82e-05	185	131	6	02cbf492bc40abebaa93a3a208888afae72fbe06
ToppCell	10x5'-GI_small-bowel-Myeloid_Dendritic-DC1\|GI_small-bowel / Manually curated celltypes from each tissue	HLA-DOB WDFY4 DSCAML1 HMSD CLIC2 ARHGAP20	1.82e-05	185	131	6	23ffba9216729b5bdb30b35742ba2627bb1200bf
ToppCell	10x5'-Liver-Myeloid_Dendritic-DC1\|Liver / Manually curated celltypes from each tissue	HLA-DOB WDFY4 ADAM28 HMSD CLIC2 KIT	1.88e-05	186	131	6	e823529ffd06352c6bdec102f221fdf27f7c7369
ToppCell	COPD-Myeloid-DC_Mature\|COPD / Disease state, Lineage and Cell class	HLA-DOB ITGA4 DSCAML1 HMSD CLIC2 KIT	1.99e-05	188	131	6	de93ccb53edb8599da9e312db0e3af604c21f673
ToppCell	IPF-Myeloid-DC_Mature\|Myeloid / Disease state, Lineage and Cell class	HLA-DOB ITGA4 DSCAML1 HMSD CLIC2 KIT	2.05e-05	189	131	6	49e67d298d045f29136919b7d9971b6502b0efaa
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL MFAP3L SYNE2 AKAP11 ARHGAP20 TOP2B	2.18e-05	191	131	6	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL MFAP3L SYNE2 AKAP11 ARHGAP20 TOP2B	2.18e-05	191	131	6	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL MFAP3L SYNE2 AKAP11 ARHGAP20 TOP2B	2.18e-05	191	131	6	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 ITGA4 THSD1 DYSF CLIC2 AFDN	2.24e-05	192	131	6	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 MYO6 THSD1 DYSF AFDN KIT	2.24e-05	192	131	6	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 THSD1 DYSF HMCN1 DCLK2 KIT	2.24e-05	192	131	6	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 MYO6 THSD1 DYSF AFDN KIT	2.24e-05	192	131	6	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 SYT6 LRRTM3 SVEP1 HMCN1 SNAI2	2.31e-05	193	131	6	cf2461af78f65616ce40d552ee9452295e3895ed
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 THSD1 DYSF HMCN1 SBF2 KIT	2.31e-05	193	131	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX17 OGT KDM4C ZBTB37 SYNE2 MACF1	2.31e-05	193	131	6	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 SYT6 LRRTM3 SVEP1 HMCN1 SNAI2	2.31e-05	193	131	6	6ef9007c9d18fb775d08fb20cdf954a28d54d7eb
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 ITGA4 THSD1 DYSF CLIC2 AFDN	2.31e-05	193	131	6	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 SYT6 LRRTM3 SVEP1 HMCN1 SNAI2	2.31e-05	193	131	6	e4ea7ce011a80b81b841c907719aa532bed39d2e
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYO6 SVEP1 SNAI2 MACF1 ARHGAP20 EPHA5	2.38e-05	194	131	6	f2f7b9aad7588c8020a4850ff9333e1db8eafac7
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 DYSF HMCN1 MACF1 AFDN KIT	2.38e-05	194	131	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM HLA-DOB WDFY4 ADAM28 NETO1 OR7A17	2.45e-05	195	131	6	3311a1bf4ed94820b45047d44fc14b14ac72e6fb
ToppCell	COVID-19_Severe-CD8+_Tem\|COVID-19_Severe / Disease condition and Cell class	MYO6 CTSC ITGA4 TLN1 SYNE2 MACF1	2.45e-05	195	131	6	ff7ae62393e1c858a10592db8e6d9f36b8bae396
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MXRA5 CTSC ADAM28 SVEP1 SNAI2 ARHGAP20	2.52e-05	196	131	6	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX17 OGT KDM4C ZBTB37 SYNE2 MACF1	2.59e-05	197	131	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Monocytes-cDCs\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	CUL1 HLA-DOB WDFY4 ADAM28 CLIC2 KIT	2.59e-05	197	131	6	15cb9fe1c3bab80bd24728fd9ac7ba385912ac33
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL11A1 MXRA5 SVEP1 TMTC1 SNAI2 FKBP7	2.59e-05	197	131	6	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCA4 ZNF571 ADAM28 FAM83B FSD1L SYNE2	2.59e-05	197	131	6	6b6504c47c309bac4f790e2f372d454bbdea49e8
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-DOB THOC5 BRPF1 BEND7 ZNF426	2.61e-05	118	131	5	08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-DOB THOC5 BRPF1 BEND7 ZNF426	2.61e-05	118	131	5	3b077ad5c68c01b3fcc93f203cb130bb90705af9
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM HLA-DOB ITGA4 WDFY4 ADAM28 NETO1	2.67e-05	198	131	6	4aa4ae2571effcfb6eb6923f7173cd3e7e4af9ef
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL11A1 MXRA5 SYT6 LRRTM3 SVEP1 SNAI2	2.67e-05	198	131	6	a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL11A1 MXRA5 SYT6 LRRTM3 SVEP1 SNAI2	2.67e-05	198	131	6	8b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCell	tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	CTSF MXRA5 SVEP1 SNAI2 PLA2G2A FKBP7	2.67e-05	198	131	6	74f2c7ef702b25a5b99e56121229e678ed992524
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL11A1 MXRA5 SYT6 LRRTM3 SVEP1 SNAI2	2.67e-05	198	131	6	4739b2e4ab141c66772e61686b45614a1839483e
ToppCell	BAL-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DOB ITGA4 WDFY4 ADAM28 HMSD CLIC2	2.74e-05	199	131	6	0b20ae65b9340d844e271acda9e116d98fc1cc69
ToppCell	BAL-Severe-Myeloid-cDC-cDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DOB ITGA4 WDFY4 ADAM28 HMSD CLIC2	2.74e-05	199	131	6	bb9e7418468b88cdfaa78788d062362794ea8230
ToppCell	BAL-Severe-Myeloid-cDC-cDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DOB ITGA4 WDFY4 ADAM28 HMSD CLIC2	2.74e-05	199	131	6	9a0e853693e572c63b135f937b2cffd4dd4026fb
ToppCell	Severe_COVID-19-Myeloid-cDC\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	HLA-DOB ITGA4 WDFY4 ADAM28 HMSD CLIC2	2.74e-05	199	131	6	9132c1929d3445fcca49f76f010ca37adeb70315
ToppCell	BAL-Severe-Myeloid-cDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DOB ITGA4 WDFY4 ADAM28 HMSD CLIC2	2.74e-05	199	131	6	d017848256704ae7237030868b143c3f0842a9c3
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLT1 MYO6 THSD1 SYNE2 MACF1 AFDN	2.82e-05	200	131	6	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Biopsy_Other_PF-Mesenchymal-Fibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	MXRA5 ABCC9 SVEP1 HMCN2 PLA2G2A FKBP7	2.82e-05	200	131	6	9996b6887cf2b1936e10a1aa396f09fd8da5f4c4
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLT1 MYO6 THSD1 SYNE2 MACF1 AFDN	2.82e-05	200	131	6	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FLT1 THSD1 DYSF MACF1 AFDN DCLK2	2.82e-05	200	131	6	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO6 ITGA4 THSD1 SYNE2 MACF1 AFDN	2.82e-05	200	131	6	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLT1 THSD1 SYNE2 MACF1 AFDN DCLK2	2.82e-05	200	131	6	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	DDX17 MYO6 ITGA4 THSD1 DYSF AFDN	2.82e-05	200	131	6	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	Sepsis-Leuk-UTI-Myeloid-cDC1\|Leuk-UTI / Disease, condition lineage and cell class	HLA-DOB MFSD2B WDFY4 ADAM28 CLIC2 KIT	2.82e-05	200	131	6	186852d54eced4c036876cc891773605068b56b5
ToppCell	LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VIPR2 FSD1L EYS FEN1 RIMS1	6.97e-05	145	131	5	90ca38c02325c5c637c32efdef634b54cc3cd105
ToppCell	Transverse-Dendritic_cell-cDC1\|Dendritic_cell / Region, Cell class and subclass	HLA-DOB DYSF WDFY4 CLIC2 TSTD3	8.44e-05	151	131	5	6870f3b5d2bfad849c3203658b5f28f0ae181295
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HLA-DOB ITGA4 WDFY4 ADAM28 CLIC2	8.71e-05	152	131	5	0769857f25da2e6169420818e61d65e33b7277b1
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DOB WDFY4 CLIC2 DCLK2 ARHGAP20	9.26e-05	154	131	5	5967a0a33456d5930fc492a700ebb015ac050abb
ToppCell	343B-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	HLA-DOB WDFY4 ADAM28 NETO2 ARHGAP20	9.26e-05	154	131	5	71d33b5dbfab5820e3daddb01806a69116ba8008
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DOB WDFY4 CLIC2 DCLK2 ARHGAP20	9.55e-05	155	131	5	fab281db4c275d51240b122be78713c839ba5a95
ToppCell	COVID-19-APC-like-Alveolar_macrophages\|COVID-19 / group, cell type (main and fine annotations)	CTSF ADAM28 ZNF182 ZNF776 EYS	9.84e-05	156	131	5	735ade77cfa16b9386a0c7ec2bd14bd2e78a51ad
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4\|GI_large-bowel / Manually curated celltypes from each tissue	SBF2 ZNF283 SEC24B TSTD3 MDGA1	9.84e-05	156	131	5	01f2c0c6a936dfb59bc727feef428a906ad2a80b
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DOB WDFY4 ADAM28 CLIC2 ARHGAP20	1.01e-04	157	131	5	19c0599a669803c4db1f174de1ce755e562a50a3
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL11A1 DSCAML1 SVEP1 HMCN1 EPHA5	1.11e-04	160	131	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	VIPR2 MYOT SVEP1 HMCN2 ARHGAP20	1.11e-04	160	131	5	8a41e2c96e0e170ac35daf6c403bf961b8d7c30b
ToppCell	TCGA-Bladder-Solid_Tissue_Normal\|TCGA-Bladder / Sample_Type by Project: Shred V9	VIPR2 MYOT SVEP1 HMCN2 ARHGAP20	1.11e-04	160	131	5	d6678996e12eaf2b735f1dfae32418cb2fabf268
ToppCell	TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue\|TCGA-Bladder / Sample_Type by Project: Shred V9	VIPR2 MYOT SVEP1 HMCN2 ARHGAP20	1.11e-04	160	131	5	c8dc575562b463fd30832d322c28006f18f7ab9c
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL11A1 DSCAML1 SVEP1 HMCN1 EPHA5	1.11e-04	160	131	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPHB3 USP45 CTSC DNAH14 ZNF92	1.14e-04	161	131	5	7c9d4410d7142a5f3a05418c994f69978c9ffa17
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCB5 SVEP1 PLA2G2A ZNF723 ARHGAP20	1.14e-04	161	131	5	a006491c991e6a134be20ad75092a91f3b7c3c91
Computational	Genes upregulated in subsets of cells of a given type within various tumors	COL11A1 MXRA5 DDX17 OGT MACF1	1.10e-05	50	64	5	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Computational	Genes upregulated in subsets of cells of a given type within various tumors	DDX17 ITGA4 SYNE2 MACF1	1.98e-04	49	64	4	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Disease	Piebaldism	SNAI2 KIT	1.72e-05	2	123	2	C0080024
Disease	piebaldism (is_implicated_in)	SNAI2 KIT	1.72e-05	2	123	2	DOID:3263 (is_implicated_in)
Disease	Spondyloepiphyseal Dysplasia	COL2A1 FLT1 COL11A1	3.80e-05	16	123	3	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	COL2A1 FLT1 COL11A1	3.80e-05	16	123	3	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	COL2A1 FLT1 COL11A1	3.80e-05	16	123	3	C4551479
Disease	Schwartz-Jampel Syndrome	COL2A1 FLT1 COL11A1	3.80e-05	16	123	3	C0036391
Disease	Melnick-Needles Syndrome	COL2A1 FLT1 COL11A1	3.80e-05	16	123	3	C0025237
Disease	Van Buchem disease	COL2A1 FLT1 COL11A1	4.61e-05	17	123	3	C0432272
Disease	Osteochondrodysplasias	COL2A1 FLT1 COL11A1	6.52e-05	19	123	3	C0029422
Disease	Dyschondroplasias	COL2A1 FLT1 COL11A1	6.52e-05	19	123	3	C0013366
Disease	Multiple Epiphyseal Dysplasia	COL2A1 FLT1 COL11A1	7.65e-05	20	123	3	C0026760
Disease	cancer (implicated_via_orthology)	FLT1 DDX17 PIK3CD FEN1 MACF1 KIT TOP2B	1.37e-04	268	123	7	DOID:162 (implicated_via_orthology)
Disease	Stickler syndrome	COL2A1 COL11A1	1.71e-04	5	123	2	cv:C0265253
Disease	Stickler syndrome, type 1	COL2A1 COL11A1	1.71e-04	5	123	2	C2020284
Disease	alcohol use disorder (implicated_via_orthology)	KDM3A VIPR2 DDX17 KDM4C CLIC2 PIK3CD	1.73e-04	195	123	6	DOID:1574 (implicated_via_orthology)
Disease	leiomyosarcoma (is_marker_for)	FLT1 KIT	2.56e-04	6	123	2	DOID:1967 (is_marker_for)
Disease	retinitis pigmentosa	ITGA4 EYS	2.56e-04	6	123	2	MONDO_0019200
Disease	Disorder of eye	COL2A1 MKKS COL11A1 ABCA4 EYS RIMS1	2.71e-04	212	123	6	C0015397
Disease	melanoma (is_marker_for)	FLT1 PPARGC1A KIT	3.52e-04	33	123	3	DOID:1909 (is_marker_for)
Disease	posterior thigh muscle fat infiltration measurement	CTSF DYSF HMCN2	4.20e-04	35	123	3	EFO_0020934
Disease	autism spectrum disorder (implicated_via_orthology)	NRCAM DSCAM DSCAML1 ITPR3 RIMS1	4.50e-04	152	123	5	DOID:0060041 (implicated_via_orthology)
Disease	melanoma	COL2A1 FLT1 KDM4C ABCB5 TRRAP KIT	6.21e-04	248	123	6	C0025202
Disease	pneumonia (implicated_via_orthology)	ITGA4 MUC2	7.59e-04	10	123	2	DOID:552 (implicated_via_orthology)
Disease	allergic conjunctivitis (is_marker_for)	PLA2G2A MUC2	7.59e-04	10	123	2	DOID:11204 (is_marker_for)
Disease	neutrophil percentage of leukocytes	COL2A1 MFSD2B SEC31A ITGA4 LCT ZNF92 BEND7 AKAP11 KIT	1.06e-03	610	123	9	EFO_0007990
Disease	xanthine measurement	COL2A1 EYS	1.30e-03	13	123	2	EFO_0010548
Disease	colitis (implicated_via_orthology)	PPARGC1A MUC2	1.30e-03	13	123	2	DOID:0060180 (implicated_via_orthology)
Disease	Down syndrome (implicated_via_orthology)	DSCAM DSCAML1	1.75e-03	15	123	2	DOID:14250 (implicated_via_orthology)
Disease	amenorrhea, response to antineoplastic agent	TMTC1 RIMS1	1.75e-03	15	123	2	EFO_0010269, GO_0097327
Disease	osteoarthritis (implicated_via_orthology)	COL2A1 COL11A1	1.75e-03	15	123	2	DOID:8398 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	KDM3A FLT1 COL11A1 ABCA4 NRCAM DYSF THOC5 BEND7 SYNE2 SNAI2 MACF1 KIT	1.80e-03	1074	123	12	C0006142
Disease	diabetic retinopathy (implicated_via_orthology)	ITGA4 PPARGC1A	1.99e-03	16	123	2	DOID:8947 (implicated_via_orthology)
Disease	SARS-CoV-2 antibody measurement, response to COVID-19 vaccine	COL11A1 DSCAM MYBPC1	2.23e-03	62	123	3	EFO_0803360, EFO_0803362
Disease	muscular dystrophy (is_implicated_in)	MYOT DYSF	2.25e-03	17	123	2	DOID:9884 (is_implicated_in)
Disease	carcinoma (implicated_via_orthology)	FLT1 SNAI2 KIT	2.45e-03	64	123	3	DOID:305 (implicated_via_orthology)
Disease	Age-related macular degeneration	ABCA4 HMCN1	2.52e-03	18	123	2	cv:C0242383
Disease	systemising measurement	DSCAM PIK3CD	3.44e-03	21	123	2	EFO_0010221
Disease	age at menarche	COL11A1 DSCAM MYO6 KDM4C DSCAML1 FAM83B CELF1 EPHA5	3.51e-03	594	123	8	EFO_0004703
Disease	eosinophil count	HLA-DOB KDM4C CTSC ABCB5 SEC31A ITGA4 DYSF SVEP1 ITPR3 NCOR2 PIK3CD SBF2 MUC2 KIT	3.68e-03	1488	123	14	EFO_0004842

Protein segments in the cluster

Peptide	Gene	Start	Entry
NECGKTFSRSSNFAK	ZNF286A	441	Q9HBT8
YFQDKAAGNFATKCI	AFDN	46	P55196
TSYRFKSLKQCVAAG	ACSM6	331	Q6P461
SKASLAAACSGVIYF	ABCA4	756	P78363
VADKSCYNRNEGGSK	ADAM28	526	Q9UKQ2
EIFGKDAKSASQNCY	ADAM21	516	Q9UKJ8
KQTNLSKCFGFVSYD	CELF1	436	Q92879
TSKKAQIIGSCYAFS	ABCB5	911	Q2M3G0
GSKDQTSKVAFKYCQ	ALG5	111	Q9Y673
SKKGFYLAFQDVGAC	EPHA5	206	P54756
KKEYTVQQALFCTSG	AKAP11	761	Q9UKA4
FNKQRYKAVTDACSL	ABCC9	776	O60706
NSRFTYTALKDGCTK	COL2A1	1426	P02458
SNECKRNFVAVYDGS	NETO1	226	Q8TDF5
ASCAAAAQRNASSYK	ITPR3	1556	Q14573
AQGKYKAFSTCASHL	OR7A5	231	Q15622
YKFSNSGSRITCAKQ	PLA2G2A	86	P14555
DKAAATCFARNKTTY	PLA2G2A	111	P14555
VGSAACLFQVSAKAY	MDGA1	621	Q8NFP4
VGSKTVSQCKNFYFN	NCOR2	641	Q9Y618
PNSYGSVKDVCTAKF	MKKS	341	Q9NPJ1
NITKVSFSDRGKYTC	MFAP3L	111	O75121
GRYCENKTSFSTAKF	EYS	2966	Q5T1H1
SAFKHNGTVECKAYN	KIT	481	P10721
QKDSTGTYTCVARNK	NRCAM	516	Q92823
FDLKTSKRVYNFCAQ	SBF2	1816	Q86WG5
SKRVYNFCAQDGQSA	SBF2	1821	Q86WG5
AQKDCKSYSVGVAYK	FSD1L	391	Q9BXM9
HYSCIAANAVGEKTK	HMCN2	2521	Q8NDA2
AQVSDKGLYSCKVSN	HMCN2	3101	Q8NDA2
CASNEPFRKVDYTKN	DCLK2	146	Q8N568
CTNRKNSKGSDTAYR	COL11A1	61	P12107
KNKAPAFYRLCSSSD	FAM83B	791	Q5T0W9
QSLEGKRKAFYTCAS	OR4A15	256	Q8NGL6
KLACSDNKTNVIYGF	OR51A7	186	Q8NH64
NDLYSSGAKIKVDCN	MUC2	826	Q02817
SQICKDSSYKNGSRD	INTS2	1161	Q9H0H0
NIAGVFNKSCAISYT	LSS	691	P48449
VKEFRQLANSGKYCT	KDM4C	96	Q9H3R0
ASAKFYASVVRCNGF	LCT	1826	P09848
RAFYKKCASTTAGFA	EPHB3	206	P54753
SLEFSGYKAGVCKQA	MFSD2B	436	A6NFX1
KVTAGYTGIKCTNFS	MACF1	206	Q9UPN3
YEVCVTGGSRSNKFK	PCDHB12	751	Q9Y5F1
CTATNTAGYAKRKVQ	HMCN1	1051	Q96RW7
CKAINIAGTSQKYFN	HMCN1	1431	Q96RW7
YVCVAENTAGSAKKY	HMCN1	2941	Q96RW7
KDQYRSCDNVSAKSS	RIMS1	1326	Q86UR5
CGRKQFFKSNYADLD	PPARGC1A	751	Q9UBK2
CGIENQAFYKLEKSS	FRMD5	286	Q7Z6J6
KDGSKFYCSRTQNEG	FKBP7	66	Q9Y680
ASCAALVKAGKVYAA	FEN1	161	P39748
KRKNCQQGAAYKTFS	KDM3A	691	Q9Y4C1
QAKADCYFTNGTEKV	HLA-DOB	36	P13765
TNDCSRNVYIKKNGF	FBXO45	116	P0C2W1
SGAYQCFATRKAQTA	DSCAML1	381	Q8TD84
SKGELVTNCFKNRYT	CUL1	586	Q13616
CTKVKQFVSSDLGSY	HYAL4	351	Q2M3T9
CFTGKKVGTASENVY	CTSC	136	P53634
CNFSAEKAKVYINDS	CTSF	366	Q9UBX1
AQKQCRKSSFAFYQA	ANKRD9	26	Q96BM1
TSKECHYSIQKGAAF	CSAD	186	Q9Y600
KQKLCYVSQGNASFT	DNAH14	1111	Q0VDD8
SCGADKSIYFRTAQK	MAPKBP1	586	O60336
DYVKKFGENFASCQA	ITGA4	186	P13612
FTDSCGKFYQATIKQ	HMSD	76	A8MTL9
GAIKVFTEKYCTANH	BEND7	351	Q8N7W2
QQVADDYGKCSRLKS	DDX17	261	Q92841
GAEVCSAIFSKNSKY	CSTF1	306	Q05048
DFYKKLALDCSGQQT	SEC24B	846	O95487
DAYCSAVFAGVKKRT	DYSF	21	O75923
DVGCNLFAKFSAYIK	CLIC2	111	O15247
YCNLANALKEKGSVA	OGT	296	O15294
ASQEARYKAFGTCVS	OR52K1	231	Q8NGK4
ASQEARYKAFGTCVS	OR52K2	231	Q8NGK3
REATKFAANYCRSGK	PDHA2	261	P29803
GAYQCFVRKDKLSAQ	DSCAM	381	O60469
FAKDIGNCAYSKTIT	ARHGAP20	201	Q9P2F6
ATKSCGKINFSLRYD	SYT6	226	Q5T7P8
QKTVKNRSCVYGSSA	SPATA31C2	1036	B4DYI2
YGAKLCNIFSTKFTV	TOP2B	186	Q02880
DTSFQKCGEIYKNLA	SYNE2	536	Q8WXH0
KNYSICGKSTTERFD	LRRTM3	356	Q86VH5
AQGKYKAFSTCASHL	OR7A10	231	O76100
NLCNKTYSTFSGLAK	SNAI2	131	O43623
SNECKRNFVAVYDGS	NETO2	231	Q8NC67
AQGKYKAFSTCASHL	OR7A17	231	O14581
LAFTFGSKVTYRCNK	SVEP1	1861	Q4LDE5
ANGTSFSVRKTAYCD	BRPF1	431	P55201
KVAAQCSHAAVSAYK	PTRH2	81	Q9Y3E5
KKAGTYFSNQAVRAC	PDCD11	316	Q14690
RSSAENKYDNGCAKL	ZNF182	176	P17025
KHECGRAFNKSSNYT	ZNF92	566	Q03936
KQCGKVFISFSSIQY	ZNF20	286	P17024
TTTQSKVFQCGKYAN	ZNF676	106	Q8N7Q3
IYCAKSFNQKGSLDR	ZBTB37	376	Q5TC79
NSYKLEECGKAFNVS	ZNF724	196	A8MTY0
KQCGKAFSYLNSFRT	ZNF136	451	P52737
SATCKNASVGDKVLY	USP45	716	Q70EL2
YTCDKTVFKNRGLAF	TMTC1	131	Q8IUR5
KALCGFTEAAAQAAY	TLN1	1431	Q9Y490
EASSFYNFCSRNKDK	STYXL2	526	Q5VZP5
GKNKYCFDFGISSRS	THSD1	311	Q9NS62
EECGKAFNQYSTLNK	ZNF723	456	P0DPD5
VFYNNDRSKAFKSFC	WDFY4	2496	Q6ZS81
YCRANKTKSSQGASN	WAPL	296	Q7Z5K2
KTNNSEKFERFRGYC	PIK3CD	946	O00329
CAYFEVSAKKNTNVD	RASD2	166	Q96D21
SFSKYSSVQKAVCQG	SCLT1	26	Q96NL6
CSSSGIVYKVQFDTK	ZNFX1	421	Q9P2E3
NFYSKAGNISKNCTS	VIPR2	81	P41587
TQTKDKCYGFSDRIQ	ZNF180	266	Q9UJW8
NQCGKSFSQSYKLVA	ZNF180	496	Q9UJW8
CDKYGKVFHKFSNSN	ZNF253	146	O75346
NKKTNAQYLFADRSC	ZCCHC4	166	Q9H5U6
KYECGKSFNQDSNLT	ZNF493	111	Q6ZR52
KCEQYGKTFNQSSTL	ZNF493	166	Q6ZR52
REKSFQCNDSGKAYN	ZNF765	211	Q7L2R6
KGNCHNFYTAISKDV	TSTD3	16	H0UI37
NKCGKSFSQSTYLIE	ZFP2	301	Q6ZN57
KYEECGKAFNRSSTL	ZNF732	251	B4DXR9
LFVQATAYGQACDKT	THOC5	271	Q13769
VCGDNLKYSTKFLSN	WNT9B	161	O14905
SQGFINYCQKKIDAS	SEC31A	451	O94979
CKATNQKGSVESSAY	FLT1	731	P17948
SKCGKAFRDGSYLTQ	ZNF329	346	Q86UD4
KECGKTFFRGSQLTY	ZNF571	366	Q7Z3V5
QQGLAKCYSVAFEKS	TRRAP	3341	Q9Y4A5
KNEKYCIFANFSVTG	WDR5	256	P61964
KECGKAFNYSNSFQI	ZNF426	311	Q9BUY5
GKYQTSSKLFQNCSE	TMEM87A	116	Q8NBN3
YSDKGCKTVQSRLDF	TOR1B	321	O14657
LYQRKEFGKTFTCGS	ZNF283	626	Q8N7M2
SYRSNAKGTSFVKNC	ZNF776	141	Q68DI1
SFSDRGVYKCVASNA	MXRA5	2016	Q9NR99
RGCTRYFANKETDKQ	MYO6	276	Q9UM54
YACVAKNRAGEATFT	MYOT	321	Q9UBF9
KAKDNFAGNYRCEVT	MYBPC1	131	Q00872